Drug resistance to antifungal medications is widely witnessed during treatment of aspergillosis infections, which is expected to restrain growth of the acute invasive aspergillosis treatment market
Increasing prevalence of naïve infectious chronic diseases such as chronic kidney disease around the globe is the major factor propelling demand for medical membrane.